Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged S. P. Tulsian

United Spirits Shareholders Get Huge Diwali Gift



United Spirits’ shareholders got the best Diwali Gift possible and are delirious with joy. Rarely does it happen in one’s lifetime that a stock rockets 35% in one trading session. And that too after having doubled in 6 months. Early investors like Rakesh Jhunjhunwala, Utpal Sheth, S. P. Tulsian & N. Jaykumar have taken home the loot

Is Rakesh Jhunjhunwala Buying United Spirits?



Rumors are rife that Rakesh Jhunjhunwala is behind the steep rise in the United Spirits stock price

Recent Multibagger Stock Recommendations



Recent Multibagger Stock Recommendations

We are constantly on the lookout for multibagger stock tips & recommendations because you never know which stock may suddenly give you that huge profit you’ve always only dreamt about

Multibagger Stocks 2012



Multibagger stocks are for the brave investor willing to take high risk for high return. We offer some multibagger stock picks and recommendations

Zydus Wellness S. P. Tulsian’s stock pick soars 15%



Happily for S. P. Tulsian, Zydus Wellness has soared to Rs. 427 as of today, giving handsome returns of 15%

Newer Entries →

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
  • Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
    Aditya Birla Capital has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Management has reiterated guidance on both growth & credit cost fronts. Lending business expected to grow at 30%. TP (+37%)... Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!